Serum fractions from normal subjects obtained by gel chromatography have been investigated using three different assay systems: radioimmunoassay (RIA), radioligand receptor assay (RRA), and testosterone production assay (TPA). The bulk of immunoassayable and "bioassayable" LH-activity was found in two fractions differing widely in their molecular size. The slower moving component, designated as "little" LH, migrated identical to the radioiodinated pituitary hormone (LER 960) with a molecular weight of about 30 000, while "big" LH appeared in an elution volume consistent with a molecular weight range between 140 000 and 180 000. Concordance was seen between the LH-activities measured in all three assay systems. The RRA/RIA ratio varied between 1.6 and 8.9, the RRA/TPA ratio was close to unity. Treatment with 6 m urea and 0.1 % mercaptoethanol and also, exposure to different pH values and salt concentrations did not change the elution position of the two LH components. Also, "big" and "little" LH appeared unaltered after re-filtration and no conversion each other could be found. In another experiment injection of gonadotrophin releasing hormone (Gn-RH) into a male induced a profound shift of LH towards the low molecular weight species. Kinetic uptake studies with "big" and "little" LH using RRA showed identical affinities to the receptor preparation. Ion exchange chromatography of serum, however, did not give two LH components, indicating no major differences in charge properties. This finding could be confirmed by preparative gel isoelectric focusing. The RRA potencies following gel filtration were in good agreement with that applied to the column, however, the immunological activities exceeded that of loaded by a factor 3\p=n-\4. A new aspect of serum LH heterogeneity is the finding of a low molecular substance (mol. weight approximately 1000) in the outer dialysate of serum, which has LH like activity in all three assay systems.
Heterogeneity of proteohormones is a term used in different contexts: Thus, this term has been applied as "microheterogeneity" to the so-called isohormones of gonadotrophins, such as human chorionic gonadotrophin. This type of hetero¬ geneity can be detected by techniques of very high resolving power, such as gel isoelectric focusing (Brossmer et al. 1971; Graesslin et ai. 1972a) and is obviously based on charge differences of the molecular forms due to their different neuramic acid content (Graesslin et al. 1973) .
Heterogeneity, however, also applies to qualitatively identical proteohormones differing in their molecular size, in their relative immunoreactivity and their survical time in the organism. Such type of heterogeneity has been shown for insulin (Steiner 8c Oyer 1967), parathyroid hormone (Berson 8c Yalow 1968) , as well as for other proteohormones {Yalow 8c Berson 1970 Goodman et al. 1974; Rabinowitz et al. 1974) .
Although the presence of such different forms of peptide-or proteohormones has been clearly demonstrated by various techniques, only scant information is available about their biological significance.
While some forms of heterogeneity are apparently due to the presence of prohormones (Yalow 8c Berson 19736) or degradation products, recent evidence indicates, that a change in the hormonal environment might induce an endocrine organ to produce different hormone forms. This has recently been shown by Bogdanove et al. (1975) who presented a line of evidence that the target organ (the gonad of the rat) not only dictates the amount of the trophic hormone to be produced but also the kind of the trophic hormone as well. Heterogeneity has also been shown for pituitary and urinary luteinizing hormone (LH) by Rabinowitz et al. (1974) who used radioimmunoassay and radioligand receptor assay techniques. Our group, on the other hand, extending earlier preliminary experiments of Wildt et al. (1973) , has recently presented data to show the existence of two forms of serum-LH (Graesslin et al., in press).
It is the purpose of this investigation to confirm and to extend our previous observation on the size heterogeneity of LH in human serum, using various methods. Besides gel chromatography, this includes ion exchange chromato¬ graphy, preparative isoelectric focusing and various treatments of serum samples prior to chromatography, such as urea-or mercaptoethanol treatment, and dialysis as well as exposure of serum to different pH values and salt concentrations. In addition, the kinetics of binding of "big" and "little" LH fractions to a receptor preparation was studied. For determination of LH activi¬ ties three assay systems have been used based on different endpoints: a radio¬ immunoassay (RIA), a radioligand receptor assay (RRA) and an in vitro bio¬ assay based on testosterone production (TPA).
From such a study we hoped to gain more detailed information about the nature and stability of the forms of serum LH. Such information will hopefully lead to clarify the biological significance, and to explain the significant dif-ferences in serum LH measurement which have been observed by several investigators (Karg et al. 1969; Qazi et al. 1974; Reichert 8c Leidenberger 1975 (1972) . This marker has been incubated with serum at 37°C for 30 min prior to gel filtration.
The fractions were monitored at 278 nm and were collected in volumes of 10 ml.
Tubes were pooled into 9 main fractions as indicated in Fig. 1 Midgley (1966 Fig. 1 as measured in the three assay systems. molecular weight of the faster migrating fraction was found to be between 140 000 and 180 000. This hormonal form of LH has been designated as "big" LH. The more retarded peak, designated as "little" LH showed a molecular size between 20 000 and 30 000, on the basis of the protein markers used for calibration (Fig. 1). [125I]hLH appeared in the two last fractions overlapping with the low molecular weight zone of serum-LH; no radioactivity was found in the area characteristic for "big" LH. Fig. 2 shows a comparison of LH activities found in nine fractions obtained after gel filtration of serum samples, as tested in the three assay systems against the same reference preparation. Fig. 2 is a typical example of the fractionation of an individual serum and shows the distribution of LH-activities. 72-92 % of the LH-activity, as found in all three assays, was recorded in the two main LH containing zones. In few cases, activity in the RRA and in the TPA reached maximum values of up to 2000 mIU/mg protein and even more, in both the "big" and "little" LH areas.
There was a good correlation between LH-activities measured in the two "bioassays", both in respect to the elution pattern and in respect to its relative amounts (Fig. 2) . Also, the peaks of radioimmunoassayable LH-activity were eluted in the same area as the "bioassayable" LH-containing fractions (Fig. 2) and there was concordance in nearly all fractions. However, RIA-LH was always lower than RRA-or TPA-LH, when expressed in mIU/mg protein. The RRA/RIA ratio varied between 1.6 and 8.9 (see Table 1 ), while the RRA/TPA ratio was close to unity (0.8-1.1).
We consider the elution-and LH-pattern of Fig. 1 as typical; however, there was a great variation in the ratio between the amount of "big" and "little" LH found (see Table 1 ). In a number of cases, even complete absence of one of the two LH containing fractions was recorded and in few cases, some activity was found in an area corresponding to a molecular weight of approxi¬ mately 60 000. This must be inherent to the serum samples themselves because, in all cases tested, LH-like activities were fairly concordant in all three assay systems. This variability is illustrated in Fig. 3 and in Table 1 . Fig. 3 shows the LH-activities of fractions obtained from 6 individual runs.
Recovery
The LH-activities eluted from the column as tested by RRA indicated a 65-80 % recovery. However, the immunological activity exceeded that loaded by a factor of 3 to 4 (see also Discussion). It should be mentioned here, that determination of immunoreactive LH in the serum sample to be loaded has been done in native serum, while for RRA part of the sample to be chromatographed had to be pre-treated (see Method section).
Stability of "big" LH
Several other experiments were made in order to examine the possibility that "big" LH is converted to "little" LH during gel filtration. After separate re-filtration of both LH forms under identical conditions, all the LH-activity in the effluent appeared in a single peak, which migrated in a manner typical for "little" and "big" LH, respectively (Fig. 4) (Leidenberger 8c Reichert 1973; Reichert et al. 1973a ), using slope differences of dose-response curves in the same receptor assay as used here. No such slope differences between "big" and "little" LH could be detected in this study using standard conditions and LER 907 as reference preparation. (LER 907) . Each point in the figure represents the 50 %> intercept of dose-response curve obtained with the prepara¬ tions indicated, using the pre-incubation time on the ordinate. This figure shows that an inverse relation exists between the pre-incubation time and the dose required to obtain 50 %> tracer uptake inhibition. The identical slopes suggest that no major differ¬ ence exists between the three preparations in respect to their receptor binding affinities. The indirect approach of studying uptake kinetics of the two forms has been chosen, because it has not been possible to label them for direct kinetic studies. Thus, the binding affinity of cold pituitary LH has been compared relative to that of "big" and "little" serum-LH. Fig. 5 is a logarithmic plot of the doses needed after various pre-incubation times to inhibit tracer uptake by 50 %. It illustrated, that no significant differences exist between pituitary LH and the two forms in serum under the conditions used.
Gonadotrophin releasing hormone test
One hundred pg of Gn-RH was injected into a male. Serum samples were drawn before and 40 min after injection. Both samples were simultaneously applied to two columns and the fractions obtained tested in the RRA (see Fig. 6 ). A very high LH value (2000 mIU/mg) was found in the zone of "little", whereas "big" LH was absent (lower part of Fig. 6 ). Considerable LH activity, however, was also found in a zone corresponding to a molecular size of approxi¬ mately 60 000. In contrast, "little" LH was absent in the control run, which showed high activity in the area of "big" LH. In this experiment injection of Gn-RH resulted in a profound shift of the LH species into the lower molecular weight area. The biological significance of this finding is not clear and should be carefully studied. (Leidenberger et al. 1976 ). For determination of LH activity in chromatographed serum fractions, this seems, however, to be a minor problem, since the various serum constituents are fractionated during chromatography and a good correlation between RRA-and TPA-LH values can be shown (see Fig. 2 ).
In contrast, immunoreactivity of the same serum fractions of Fig. 2 Fig. 4 , which shows re-chromatography of the isolated "big" and "little" LH fractions.
Except for the size heterogeneity, no qualitative differences could be detected between "big" and "little" forms of serum LH and pituitary LH: All three forms of LH studies here showed kinetics of binding to a receptor preparation not distinguishable from each other (Fig. 5) . Also, determination of the iso¬ electric points of the "big" and "little" LH fraction by isoelectrofocusing as described above, gave an isoelectric range for both serum LH forms between 7 and 8. This finding is in good agreement with the isoelectric range found for pituitary LH (Saxena 8c Rathnam 1971; Graesslin et al. 19726) , and can be confirmed using ion exchange chromatography.
We conclude from these studies, that "big" LH is a rather stable form and is most likely not due to loose attachment of pituitary to a serum protein or due to aggregation. This view is supported by the stability of "big" LH under the various conditions, by the result of re-chromatography (Fig. 4) plasma.
An interesting feature whose biological significance awaits clarifications is the rather big variability of the relative amounts of "big" and "little" LH present in individual sera (Fig. 3, Table 1 ).
While the physicochemical characteristics of "big" LH are nearly identical with the characteristics of a "big" pituitary TSH, which has been characterized using similar techniques (Ehrhardt 1976, personal communication) , our finding of two molecular size species disagrees with that of Qazi et al. (1974) who found only one area of biological activity after gel chromatography of human plasma.
while for LH quantitation in the RRA, serum has to be pre-treated with ethanol or ether. That ethanol treatment of individual sera causes "unmasking" of immunoreactive LH has also been shown by our group (unpublished results). The demonstration of "unmasking" of LH immunoactivities after various pretreatments and of the loss of immuno-and in uiiro-bioassayable LH activity into the outer dialysate after dialysis of serum serves as a caution against oversimplified interpretation of data from sera which have to be pre-treated prior to the assay. Of course, the same scepticism should be applied to measure¬ ments in native serum or plasma, whatever assay is being used, at least until the biological significance of method interfering substances in native serum and of the various forms of LH in blood is understood.
